EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $406,000 | -21.2% | 8,196 | -19.0% | 0.01% | -17.6% |
| Q4 2021 | $515,000 | -14.3% | 10,118 | -6.1% | 0.02% | -15.0% |
| Q3 2021 | $601,000 | +44.8% | 10,771 | +11.1% | 0.02% | +42.9% |
| Q2 2021 | $415,000 | +1.7% | 9,692 | -0.8% | 0.01% | 0.0% |
| Q1 2021 | $408,000 | -57.7% | 9,775 | -39.2% | 0.01% | -60.0% |
| Q4 2019 | $965,000 | -19.4% | 16,065 | -24.1% | 0.04% | -18.6% |
| Q3 2019 | $1,197,000 | -14.4% | 21,163 | -15.8% | 0.04% | 0.0% |
| Q2 2019 | $1,399,000 | -12.3% | 25,130 | -20.4% | 0.04% | -8.5% |
| Q1 2019 | $1,595,000 | – | 31,582 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |